What is ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 is an acidic component used in the preparation of dialysate for hemodialysis. It is formulated to be mixed with a bicarbonate concentrate and purified water to create a final dialysate solution. This dialysate facilitates the exchange of solutes and removal of toxins from the blood during dialysis sessions.
Composition per Liter:
Sodium Chloride: 161.43 g
Potassium Chloride: 5.49 g
Calcium Chloride: 9.75 g
Magnesium Chloride: 3.74 g
Glacial Acetic Acid: 8.85 g
Purified Water: q.s. to 1 liter
Medex
+2
Medex
+2
My Health Box
+2
Key Features:
Provides essential electrolytes to maintain physiological balance during dialysis.
Contains acetic acid to stabilize the pH of the dialysate solution.
Designed for use with bicarbonate concentrates in a three-stream dialysis system
How to use ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
Preparation:
Dilution: Mix the acid concentrate with a bicarbonate concentrate and purified water in a three-stream dialysis machine. The typical dilution ratio is:
Acid Concentrate: 1 part
Bicarbonate Concentrate: 1.83 parts
Purified Water: 34 parts
Medex
Mixing: Ensure thorough mixing to achieve a homogeneous dialysate solution.
Quality Control: Verify the conductivity and pH of the final dialysate to ensure it meets prescribed standards.
Administration:
The prepared dialysate is delivered to the dialyzer where it facilitates the exchange of waste products and electrolytes between the patient's blood and the dialysate.
Precautions:
Do not use the acid concentrate alone; it must be combined with a bicarbonate concentrate and purified water.
Use only with dialysis machines compatible with three-stream systems.
Ensure all components are within their expiration dates and have been stored properly
Mode of Action ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
The acid concentrate plays a crucial role in the dialysis process by contributing to the composition of the dialysate solution.
Mechanism:
Electrolyte Balance: The concentrate provides essential electrolytes (sodium, potassium, calcium, magnesium) that help maintain the patient's electrolyte balance during dialysis.
Acid-Base Regulation: Acetic acid in the concentrate helps stabilize the pH of the dialysate. During dialysis, acetic acid is metabolized to bicarbonate in the body, aiding in correcting metabolic acidosis.
PMC
Osmotic Gradient: The presence of dextrose creates an osmotic gradient that facilitates the removal of excess fluid from the patient's blood.
Outcome:
The combined effect of these components ensures effective removal of waste products, maintenance of electrolyte balance, and correction of acid-base disturbances in patients undergoing hemodialysis.
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 Interactions ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
While the acid concentrate itself is not administered directly to patients, its components can interact with the patient's physiological status and medications.
Potential Interactions:
Electrolyte Levels: The electrolyte composition of the dialysate can influence serum electrolyte levels, potentially interacting with medications that affect electrolyte balance.
Acid-Base Balance: The acid-base status influenced by the dialysate can affect the pharmacokinetics of certain drugs, altering their efficacy or toxicity.
Clinical Considerations:
Monitor patients for signs of electrolyte imbalances, especially if they are on medications that affect electrolyte levels.
Adjust medication dosages as necessary based on the patient's response to dialysis and changes in laboratory values.
Dosage of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
Standard Dosage:
Typically, 5 liters of acid concentrate are used per dialysis session. This is mixed with appropriate volumes of bicarbonate concentrate and purified water to prepare the final dialysate solution.
Medex
Customization:
The exact volume may be adjusted based on the patient's individual needs, dialysis prescription, and the dialysis machine's specifications.
Administration:
The prepared dialysate is used during the dialysis session, with the flow rate and duration determined by the patient's treatment plan.
Monitoring:
Regularly monitor the patient's vital signs, electrolyte levels, and acid-base status during and after dialysis sessions to ensure treatment efficacy and safety.
Possible side effects of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
While the acid concentrate itself is not directly administered to patients, improper preparation or use can lead to adverse effects.
Potential Side Effects:
Electrolyte Imbalances: Incorrect electrolyte concentrations in the dialysate can lead to hypo- or hypernatremia, hypo- or hyperkalemia, and other disturbances.
Acid-Base Disorders: Improper acid-base balance in the dialysate can result in metabolic acidosis or alkalosis.
Hypotension: Rapid fluid removal or incorrect dialysate composition can cause low blood pressure during dialysis.
Muscle Cramps: Electrolyte shifts during dialysis may lead to muscle cramps.
Preventive Measures:
Ensure accurate preparation of the dialysate with correct concentrations of all components.
Monitor patients closely during dialysis sessions for any signs of adverse effects.
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 Contraindications ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
Absolute Contraindications:
Known hypersensitivity to any component of the concentrate.
Relative Contraindications:
Hyperkalemia: Use with caution in patients with elevated serum potassium levels, as the concentrate contains potassium chloride.
Hypercalcemia: Patients with high serum calcium levels should be monitored closely due to the calcium content in the concentrate.
Clinical Considerations:
Evaluate the patient's electrolyte levels and overall clinical status before initiating dialysis with this concentrate.
Adjust the dialysate composition as necessary to meet individual patient needs.
Storage of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04
Storage Conditions:
Store at temperatures below 30°C.
Medex
Keep the container tightly closed when not in use.
Protect from light and moisture.
Shelf Life:
Use before the expiration date indicated on the container.
Once opened, the solution should be used within 96 hours.
Medex
Handling Precautions:
Inspect the solution for any visible particles or discoloration before use.
Do not use if the solution appears cloudy or contains precipitates.
Dispose of any unused solution according to local regulations.
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 features an exceptional active ingredient renowned for its potent effects, comprising Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride. This powerful formulation provides a superior solution for addressing diverse health concerns. With Combination concentration and an easily manageable Dialysis Fluid, it remains a preferred option for countless individuals seeking effective treatment.
Introduction
All you need to know about ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 .
Welcome to Dwaey, specifically on ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 page.
This medicine contains an important and useful components, as it consists of Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride.
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 is available in the market in concentration Combination and in the form of Dialysis Fluid.
KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO) is the producer of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 and it is imported from KUWAIT,
The most popular alternatives of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 are listed downward .
-
Active Substance
Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride
-
Size
-
Indications
- No indications available.
-
Type
-
Company
KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO)
Frequently Asked Questions
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 should be stored according to the instructions provided by KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO).
In general, it is recommended to store ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04. Some medications, including
ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration Combination,
and the specific recommendations of KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO).
The effects of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration Combination, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 with or without food may vary depending on the medication
and the recommendations of KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO). Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 in children or elderly individuals may depend on various factors, including
the specific medication, type Dialysis Fluid, and the recommendations of KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES CO. (KSPICO). Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of ACID CONCENTRATE FOR BICARBONATE HAEMODIALYSIS KSP-04 in children or elderly individuals.
Dwaey
All medical information published on the Dwaey website aims to increase medical awareness and health education among users. However, it is not a substitute for professional medical advice. Always consult with a specialist doctor. We strongly advise against using any information or medicine found on the site without referring to your healthcare provider.
Related Products
0 Comments